Discount contracts for medicines containing the active substance Betamethasone, ATC D07XC01, under an open-house model

Summary

The tender concerns non-exclusive discount contracts for medicines containing Betamethasone (ATC D07XC01). The objective is to award discount contracts under an open-house model for the period from 01 November 2026 to 31 October 2028, with contracts possibly being concluded at any time in accordance with the tender documents. The tender documents contain the precise qualification, suitability and compliance requirements.